Trump announces phased US tariffs on imported generic drugs; Indian pharma stocks fall despite limited impact outlook
Indian pharmaceutical stocks declined in early trade after the US President unveiled a phased tariff regime on imported generic medicines, though analysts said India's cost advantage and regulatory hurdles make a major disruption unlikely.





